而目前欧洲大部分医院中的病人只有接受溶栓治疗后无再灌注证据时才接受PCI治疗。
Current practice in most European hospitals is to administer thrombolytics and only to refer patients for PCI if they show no evidence of reperfusion.
无再灌注组2次心肌显像心肌缺损得分、随访期和基础室壁运动得分指数均无显著性差异（P均＞0．05）。
But SPECT defect score and ventricular wall motion score indices were similar between 2 events in nonreperfusion group (P>005).
除此以外，这两种再灌注方式对术后早期肝功能恢复的影响差异无统计学意义。
Besides, there is no significant difference regarding recovery of liver function early after OLT under two intraoperative reperfusion modes.
应用推荐